RFS
WINT

Rockefeller Financial Services’s Windtree Therapeutics Inc WINT Stock Holding History

Rockefeller Financial Services’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-27,658
Closed -$53K – 492
2016
Q2 		$53K Hold
27,658
– – ﹤0.01% 396
2016
Q1 		$46K Buy
+27,658
New +$59.4K ﹤0.01% 432

Other funds holding WINT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rockefeller Financial Services's WINT Position: Q3 2016 in Review

Rockefeller Financial Services sold out of Windtree Therapeutics Inc (WINT) in Q3 2016, closing a stake of 27,658 shares — an estimated $53K sold.

Rockefeller Financial Services first reported a position in WINT in Q1 2016 and held it in 2 quarters. The position peaked at $53K in Q2 2016. 33 funds tracked by Wall St. Rank hold WINT as of Q3 2016.

  • Rockefeller Financial Services reported no remaining Windtree Therapeutics Inc position as of Q3 2016 after selling out during the quarter.
  • Rockefeller Financial Services sold 27,658 Windtree Therapeutics Inc shares in Q3 2016, an estimated $53K.
  • Rockefeller Financial Services first reported a position in Windtree Therapeutics Inc in Q1 2016 and held it in 2 quarters.
  • Rockefeller Financial Services's Windtree Therapeutics Inc position peaked at $53K in Q2 2016.
  • 33 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q3 2016.

Based on Rockefeller Financial Services's 13F filing for Q3 2016, filed 28 Oct 2016.